Dual-targeting for brain-specific drug delivery: synthesis and biological evaluation.
Dual-targeting for brain-specific drug delivery: synthesis and biological evaluation.
复制标题
脑特异性药物递送的双靶向:合成和生物学评价
DOI:
10.1080/10717544.2018.1431978
复制
发表时间:
2018-11
期刊:
影响因子:
6
通讯作者:
Wu Y
中科院分区:
文献类型:
--
作者:
Yue Q;Peng Y;Zhao Y;Lu R;Fu Q;Chen Y;Yang Y;Hai L;Guo L;Wu Y
Abstract Ibuprofen is one of the most potent non-steroid anti-inflammatory drugs (NSAIDs) and plays an important role in the treatment of neurodegenerative diseases. However, its poor brain penetration and serious side effects at therapeutic doses, has hindered its further application. Thus, it is of great interest to develop a carrier-mediated transporter (CMT) system that is capable of more efficiently delivering ibuprofen into the brain at smaller doses to treat neurodegenerative diseases. In this study, a dual-mediated ibuprofen prodrug modified by glucose (Glu) and vitamin C (Vc) for central nervous system (CNS) drug delivery was designed and synthesized in order to effectively deliver ibuprofen to brain. Ibuprofen could be released from the prepared prodrugs when incubated with various buffers, mice plasma and brain homogenate. Also, the prodrug showed superior neuroprotective effect in vitro and in vivo than ibuprofen. Our results suggest that chemical modification of therapeutics with warheads of glucose and Vc represents a promising and efficient strategy for the development of brain-targeting prodrugs by utilizing the endogenous transportation mechanism of the warheads.
登录
查看更多内容
影响因子:
6.7
作者:
Qu, Boyi;Li, Xiaocen;Wu, Yong
通讯作者:
Wu, Yong
DOI:
10.3390/molecules13051035
发表时间:
2008-05-01
期刊:
Molecules (Basel, Switzerland)
影响因子:
--
作者:
Pavan B;Dalpiaz A;Ciliberti N;Biondi C;Manfredini S;Vertuani S
通讯作者:
Vertuani S
影响因子:
4.7
作者:
Teema, Asmaa M.;Zaitone, Sawsan A.;Moustafa, Yasser M.
通讯作者:
Moustafa, Yasser M.
影响因子:
6
作者:
Zhang Y;Zhai M;Chen Z;Han X;Yu F;Li Z;Xie X;Han C;Yu L;Yang Y;Mei X
通讯作者:
Mei X
影响因子:
9.1
作者:
Wu, Xue-Ying;Li, Xiao-Cen;Hai, Li
通讯作者:
Hai, Li